233 related articles for article (PubMed ID: 19950580)
1. [VIGILIN involves in regulation of imprinting gene IGF2 and H19 in human hepatocellular carcinoma cell].
Ge YJ; Xie XY; Yang B; Chai XJ; Zhang YC; Qin Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 40(5):770-4. PubMed ID: 19950580
[TBL] [Abstract][Full Text] [Related]
2. [Construction of shRNA eucharyotic expression plasmid targeted human VIGILIN and the investigation of VIGILIN's effect on hepatocarcinoma cell cycle].
Xie XY; Wei L; Yang WL; Ge YJ; Qin Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 39(4):527-30, 539. PubMed ID: 18798485
[TBL] [Abstract][Full Text] [Related]
3. [The aberrant imprinting of insulin-like growth factor II and H19 in human hepatocellular carcinoma].
Wu J; Qin Y; Li B; He WZ; Sun ZL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):49-52. PubMed ID: 17294726
[TBL] [Abstract][Full Text] [Related]
4. Vigilin interacts with CCCTC-binding factor (CTCF) and is involved in CTCF-dependent regulation of the imprinted genes Igf2 and H19.
Liu Q; Yang B; Xie X; Wei L; Liu W; Yang W; Ge Y; Zhu Q; Zhang J; Jiang L; Yu X; Shen W; Li R; Shi X; Li B; Qin Y
FEBS J; 2014 Jun; 281(12):2713-25. PubMed ID: 24725430
[TBL] [Abstract][Full Text] [Related]
5. Hypomethylated and hypermethylated profiles of H19DMR are associated with the aberrant imprinting of IGF2 and H19 in human hepatocellular carcinoma.
Wu J; Qin Y; Li B; He WZ; Sun ZL
Genomics; 2008 May; 91(5):443-50. PubMed ID: 18358696
[TBL] [Abstract][Full Text] [Related]
6. In situ detection of insulin-like growth factor II (IGF2) and H19 gene expression in hepatocellular carcinoma.
Sohda T; Iwata K; Soejima H; Kamimura S; Shijo H; Yun K
J Hum Genet; 1998; 43(1):49-53. PubMed ID: 9609998
[TBL] [Abstract][Full Text] [Related]
7. Expression of the imprinted IGF2 and H19 genes in the endometrium of cases with unexplained infertility.
Korucuoglu U; Biri AA; Konac E; Alp E; Onen IH; Ilhan MN; Turkyilmaz E; Erdem A; Erdem M; Menevse S
Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):77-81. PubMed ID: 20042264
[TBL] [Abstract][Full Text] [Related]
8. Imbalance in expression levels of insulin-like growth factor 2 and H19 transcripts linked to progression of hepatocellular carcinoma.
Iizuka N; Oka M; Tamesa T; Hamamoto Y; Yamada-Okabe H
Anticancer Res; 2004; 24(6):4085-9. PubMed ID: 15736456
[TBL] [Abstract][Full Text] [Related]
9. Disrupted IGF2 promoter control by silencing of promoter P1 in human hepatocellular carcinoma.
Li X; Nong Z; Ekström C; Larsson E; Nordlinder H; Hofmann WJ; Trautwein C; Odenthal M; Dienes HP; Ekström TJ; Schirmacher P
Cancer Res; 1997 May; 57(10):2048-54. PubMed ID: 9158004
[TBL] [Abstract][Full Text] [Related]
10. The H19 endodermal enhancer is required for Igf2 activation and tumor formation in experimental liver carcinogenesis.
Vernucci M; Cerrato F; Besnard N; Casola S; Pedone PV; Bruni CB; Riccio A
Oncogene; 2000 Dec; 19(54):6376-85. PubMed ID: 11175353
[TBL] [Abstract][Full Text] [Related]
11. Riboregulator H19 induction of MDR1-associated drug resistance in human hepatocellular carcinoma cells.
Tsang WP; Kwok TT
Oncogene; 2007 Jul; 26(33):4877-81. PubMed ID: 17297456
[TBL] [Abstract][Full Text] [Related]
12. [Study on the expression and genomic imprinting status of insulin-like growth factor 2 gene in hepatocellular carcinoma].
Li H; Zhang N
Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):347-9. PubMed ID: 15225429
[TBL] [Abstract][Full Text] [Related]
13. Loss of imprinting of the insulin-like growth factor 2 and the H19 gene in testicular seminomas detected by real-time PCR approach.
Stier S; Neuhaus T; Albers P; Wernert N; Grünewald E; Forkert R; Vetter H; Ko Y
Arch Toxicol; 2006 Oct; 80(10):713-8. PubMed ID: 16721595
[TBL] [Abstract][Full Text] [Related]
14. Developmentally regulated functions of the H19 differentially methylated domain.
Vernucci M; Cerrato F; Pedone PV; Dandolo L; Bruni CB; Riccio A
Hum Mol Genet; 2004 Feb; 13(3):353-61. PubMed ID: 14681296
[TBL] [Abstract][Full Text] [Related]
15. Vigilin interacts with CTCF and is involved in the maintenance of imprinting of IGF2 through a novel RNA-mediated mechanism.
Yu X; Liu Q; He J; Huang Y; Jiang L; Xie X; Liu J; Chen L; Wei L; Qin Y
Int J Biol Macromol; 2018 Mar; 108():515-522. PubMed ID: 29157910
[TBL] [Abstract][Full Text] [Related]
16. Changes in the DNA methylation profile of the rat H19 gene upstream region during development and transgenic hepatocarcinogenesis and its role in the imprinted transcriptional regulation of the H19 gene.
Manoharan H; Babcock K; Pitot HC
Mol Carcinog; 2004 Sep; 41(1):1-16. PubMed ID: 15352122
[TBL] [Abstract][Full Text] [Related]
17. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis.
Barsyte-Lovejoy D; Lau SK; Boutros PC; Khosravi F; Jurisica I; Andrulis IL; Tsao MS; Penn LZ
Cancer Res; 2006 May; 66(10):5330-7. PubMed ID: 16707459
[TBL] [Abstract][Full Text] [Related]
18. Biallelic transcription of Igf2 and H19 in individual cells suggests a post-transcriptional contribution to genomic imprinting.
Jouvenot Y; Poirier F; Jami J; Paldi A
Curr Biol; 1999 Oct; 9(20):1199-202. PubMed ID: 10531031
[TBL] [Abstract][Full Text] [Related]
19. Hypoglycemia from IGF2 overexpression associated with activation of fetal promoters and loss of imprinting in a metastatic hemangiopericytoma.
Lawson EA; Zhang X; Crocker JT; Wang WL; Klibanski A
J Clin Endocrinol Metab; 2009 Jul; 94(7):2226-31. PubMed ID: 19383775
[TBL] [Abstract][Full Text] [Related]
20. IVF results in de novo DNA methylation and histone methylation at an Igf2-H19 imprinting epigenetic switch.
Li T; Vu TH; Ulaner GA; Littman E; Ling JQ; Chen HL; Hu JF; Behr B; Giudice L; Hoffman AR
Mol Hum Reprod; 2005 Sep; 11(9):631-40. PubMed ID: 16219628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
